PTPN1 and T-cell non-Hodgkin lymphoma: Compound 1 markedly inhibited the PTP1B activity (IC50 = 0.85 μM) and showed a moderate cytotoxicity against two human cancer cell lines, HCT-15 (colon) and Jurkat (T-cell lymphoma) cells.